Holen Sie sich die Stockscreener-App
0.1883
2.94%
-0.0057
Schlusskurs vom Vortag:
$0.194
Offen:
$0.194
24-Stunden-Volumen:
273.05K
Relative Volume:
1.06
Marktkapitalisierung:
$11.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.09M
KGV:
-1.1638
EPS:
-0.1618
Netto-Cashflow:
$-8.31M
1W Leistung:
-18.13%
1M Leistung:
-27.58%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$0.184
$0.1999
1-Wochen-Bereich:
$0.184
$0.2498
52-Wochen-Spanne:
$0.184
$5.13
Abpro Holdings Inc Stock (ABP) Company Profile
Firmenname
Abpro Holdings Inc
Sektor
Branche
Telefon
248-890-7200
Adresse
6 ST JOHNS LANE, FLOOR 5, NEW YORK
Vergleichen Sie ABP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
0.1895 | 11.34M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
431.54 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
539.36 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
551.52 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
253.37 | 33.82B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
230.98 | 27.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Abpro Holdings Inc Aktie (ABP) Neueste Nachrichten
Financial Fitness Check: Examining Abpro Holdings Inc (ABP)’s Key Ratios - DWinneX
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 By Investing.com - Investing.com Canada
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 - Investing.com Australia
ABP stock plunges to 52-week low, touches $0.23 - Investing.com
Holdings of Abpro Holdings Inc (ABP) are aligned with the stars - Sete News
Closing Strong: Abpro Holdings Inc (ABP) Ends at 0.26, Down -0.27 from Last Close - DWinneX
Abpro Holdings Inc’s latest rating changes from various analysts - knoxdaily.com
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - ADVFN
ABP’s Stock Journey: What Investors Need to Know About Abpro Holdings Inc’s Performance - investchronicle.com
Analyzing ABP’s price-to-book ratio for the last quarter - uspostnews.com
Abpro Holdings Presents Promising Preclinical Cancer Data - TipRanks
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager - The Manila Times
Abpro and Celltrion Reveal Promising Preclinical Data for Bispecific T-Cell Engager ABP-102/CT-P72 Targeting HER2-Positive Cancers - Nasdaq
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing - Bluefield Daily Telegraph
Cancer Drug Shows 2X Better Tumor Suppression in Breakthrough Study | ABP Stock News - Stock Titan
Abpro Holdings CEO Acquires Additional Shares - TradingView
Stocks in play: A&W Food Services of Canada Inc - The Globe and Mail
Abpro Holdings amends convertible note terms with Yorkville - Investing.com
Abpro Holdings amends convertible note terms with Yorkville By Investing.com - Investing.com Canada
ABP stock plunges to 52-week low, touches $0.23 By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials - Investing.com Australia
Abpro Holdings, Inc. SEC 10-K Report - TradingView
Abpro Holdings approves significant stock issuance to Yorkville - Investing.com Australia
Abpro Holdings approves significant stock issuance to Yorkville By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price - Investing.com
Abpro Holdings Delays Year-End Financial Report - TipRanks
Abpro Holdings to Present Preclinical Data at AACR 2025 - TipRanks
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - The Manila Times
Groundbreaking Cancer Treatment Data: Abpro's HER2 Therapy Selected for Major AACR Showcase - Stock Titan
Abpro Chief Executive Ian Chan Departs -March 11, 2025 at 04:42 am EDT - Marketscreener.com
Abpro Statement on the Departure of Former CEO Ian Chan - The Manila Times
3 Stocks Primed for Compounding Wealth This Decade - The Globe and Mail
Why Oil and Gas Giants ExxonMobil, Chevron, and ConocoPhilips Were Down Today on an Up Day for the Market - The Globe and Mail
Reaction to Tariffs Was as Expected - The Globe and Mail
European and U.S. Futures Rise Amid Optimism Over Inflation Data and Tariff Developments - The Globe and Mail
Design Software Stocks Q4 Teardown: Adobe (NASDAQ:ADBE) Vs The Rest - The Globe and Mail
Abpro Holdings Inc Terminates Ian Chan As CEO Effective March 3, 2025 - MarketScreener
Delek Logistics Partners' Q4 Earnings Increase, Revenue Declines -February 25, 2025 at 07:41 am EST - Marketscreener.com
Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage of Abpro Holdings (ABP) with Buy Recommendation - Nasdaq
Equitable Holdings Launches $1.8 Billion Tender Offer for AllianceBernstein Units -February 24, 2025 at 06:39 am EST - Marketscreener.com
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings - The Globe and Mail
Abpro Holdings Highlights Strategic Partnerships in Biotech - TipRanks
Finanzdaten der Abpro Holdings Inc-Aktie (ABP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Abpro Holdings Inc-Aktie (ABP) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Suk Jin Wook (Miles) | CEO and Chairman |
Apr 24 '25 |
Buy |
0.34 |
26,542 |
9,024 |
125,902 |
| Suk Jin Wook (Miles) | CEO and Chairman |
Apr 23 '25 |
Buy |
0.28 |
7,460 |
2,089 |
99,360 |
2.11%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):